Is Veradermics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Veradermics Inc (MANE) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Veradermics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Veradermics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Veradermics Inc?

Muslim investors may consider investing in Veradermics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Veradermics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Veradermics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Veradermics Inc updated?

The Shariah compliance status of Veradermics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Veradermics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Veradermics Inc?

You can check the latest Shariah compliance status of Veradermics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MANE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 15, 2026

Report Source: 2026 1st Quarter Report

Veradermics Inc. Stock Analysis MANE

United States Health Care Mid Cap Report: Q1, 2026

Veradermics, Inc. is a late clinical-stage biopharmaceutical company. The company is headquartered in New Haven, Connecticut and currently employs 21 full-time employees. The company went IPO on 2026-02-04. The firm is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The firm is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss therapy and potentially transform PHL treatment. VDPHL01 is an oral, ER formulation of minoxidil, a proven hair growth agent, designed to maximize minoxidil’s impact on hair restoration while minimizing the risk of cardiac activity. The firm is conducting a Phase II clinical trial evaluating VDPHL01 in male and female patients with mild-to-moderate PHL.

Key Statistics of Veradermics Inc (MANE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$97.80$105.84

Today's Open

$103.00

Volume

476.75K

P/E Ratio (TTM)

52 Week Range

$32.00$117.71

Market Cap

4.73B

Avg. Volume

727.01K

Dividend Yield

Financial Metrics & Statements of Veradermics Inc (MANE)

FAQ's for Veradermics Inc (MANE)

According to Musaffa’s Shariah screening methodology, Veradermics Inc (MANE) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.